UDI Expands, Questions Roll In, And Debate Over System Adoption Continues
This article was originally published in The Gray Sheet
Executive Summary
As 2015 comes to a close, "The Gray Sheet" looks at the current state of the Unique Device Identification program, persistent challenges for companies and what to expect in the year ahead. UDI guru Jay Crowley provides insight.
You may also be interested in...
Medicare Agency Comes On Board With Adding UDIs To Claims Forms
The acting head of the Center for Medicare and Medicaid Services has signaled his agency's plan to support the effort to get UDIs incorporated as a standard element of insurance claims by signing a letter jointly with the FDA commissioner. Previously, CMS had worried about the move due to the significant system upgrades that hospitals and payers will need to make to support UDIs in claims.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.